Teachers Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $2.58M | Buy |
317,364
+11,637
| +4% | +$94.7K | ﹤0.01% | 1824 |
|
|
2018
Q4 | $2.47M | Buy |
305,727
+10,941
| +4% | +$88.3K | ﹤0.01% | 1723 |
|
|
2018
Q3 | $2.25M | Buy |
294,786
+11,682
| +4% | +$89.1K | ﹤0.01% | 1915 |
|
|
2018
Q2 | $1.62M | Buy |
283,104
+11,967
| +4% | +$68.6K | ﹤0.01% | 2081 |
|
|
2018
Q1 | $1.29M | Buy |
271,137
+1,138
| +0.4% | +$5.43K | ﹤0.01% | 2092 |
|
|
2017
Q4 | $1.33M | Buy |
269,999
+68,120
| +34% | +$335K | ﹤0.01% | 2086 |
|
|
2017
Q3 | $1.06M | Buy |
201,879
+5,494
| +3% | +$28.8K | ﹤0.01% | 2201 |
|
|
2017
Q2 | $1.09M | Buy |
196,385
+70,438
| +56% | +$392K | ﹤0.01% | 2179 |
|
|
2017
Q1 | $1.06M | Buy |
125,947
+170
| +0.1% | +$1.43K | ﹤0.01% | 2151 |
|
|
2016
Q4 | $796K | Buy |
125,777
+19,615
| +18% | +$124K | ﹤0.01% | 2297 |
|
|
2016
Q3 | $468K | Sell |
106,162
-11,236
| -10% | -$49.5K | ﹤0.01% | 2500 |
|
|
2016
Q2 | $333K | Buy |
117,398
+10,364
| +10% | +$29.4K | ﹤0.01% | 2639 |
|
|
2016
Q1 | $303K | Sell |
107,034
-311,100
| -74% | -$881K | ﹤0.01% | 2611 |
|
|
2015
Q4 | $4.32M | Hold |
418,134
| – | – | 0.01% | 1197 |
|
|
2015
Q3 | $4.77M | Buy |
418,134
+312,714
| +297% | +$3.57M | 0.01% | 1139 |
|
|
2015
Q2 | $1.57M | Buy |
105,420
+5,346
| +5% | +$79.8K | ﹤0.01% | 1852 |
|
|
2015
Q1 | $904K | Buy |
100,074
+1,891
| +2% | +$17.1K | ﹤0.01% | 2101 |
|
|
2014
Q4 | $1.19M | Hold |
98,183
| – | – | ﹤0.01% | 1928 |
|
|
2014
Q3 | $960K | Hold |
98,183
| – | – | ﹤0.01% | 2031 |
|
|
2014
Q2 | $1.25M | Buy |
+98,183
| New | +$1.25M | ﹤0.01% | 1925 |
|